Immunostaining studies revealed that the activity of MAO-B isoform was substantially inclined in the cortical and hippocampal regions of AD brains, demonstrating the primary neuronal loss and significant gliosis in such regions of the brain, whereas MAO-A was raised in the hypothalamus and frontal lobe. Here, MAOB is linked to Alzheimer disease.